Thomas Trimarchi, Ph.D., is a distinguished figure in the biotechnology industry, currently serving as the President and Chief Financial Officer at BRIDGEBIO PHARMA INC. Dr. Trimarchi's career is marked by a robust academic background and extensive experience in the financial aspects of biotech ventures. He holds a Ph.D. in Biochemistry from the University of California, San Francisco, where his research focused on the molecular mechanisms of neurodegenerative diseases. His transition from academia to industry was driven by a passion to bring scientific discoveries to market, thereby improving patient outcomes. At BRIDGEBIO PHARMA INC, Dr. Trimarchi plays a pivotal role in steering the company's strategic direction and financial health. As President and CFO, he oversees the company's financial operations, including budgeting, forecasting, and capital raising efforts. Under his leadership, BRIDGEBIO has successfully navigated the complex landscape of drug development and commercialization, securing significant investments to fund its innovative pipeline. His strategic vision has been instrumental in forging key partnerships and collaborations that have accelerated the development of novel therapies for genetic diseases. Dr. Trimarchi's achievements extend beyond his role at BRIDGEBIO. He has been recognized for his contributions to the biotech sector, receiving accolades for his leadership and financial acumen. Prior to joining BRIDGEBIO, he held senior financial positions at several prominent biotech firms, where he honed his skills in managing the fiscal challenges unique to the industry. His expertise in both science and finance makes him a valuable asset to BRIDGEBIO, where he continues to drive the company's mission to bridge the gap between scientific discovery and patient care.